| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |